Clinical Trial Update: A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating folate levels in women taking oral contraceptives has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hereditary and Neonatal Diseases and Abnormalities
• Nervous System Malformations
• Neural Tube Defects

Drugs mentioned

• Oral contraceptives (combined oral contraceptives)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities | Phase 3 | Status: WITHDRAWN